JNBA Financial Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-10
| Closed | -$7.19K | – | 760 |
|
2023
Q2 | $7.19K | Hold |
10
| – | – | ﹤0.01% | 501 |
|
2023
Q1 | $8.22K | Hold |
10
| – | – | ﹤0.01% | 499 |
|
2022
Q4 | $7.22K | Sell |
10
-5
| -33% | -$3.61K | ﹤0.01% | 484 |
|
2022
Q3 | $10K | Hold |
15
| – | – | ﹤0.01% | 458 |
|
2022
Q2 | $9K | Hold |
15
| – | – | ﹤0.01% | 502 |
|
2022
Q1 | $10K | Hold |
15
| – | – | ﹤0.01% | 497 |
|
2021
Q4 | $9K | Hold |
15
| – | – | ﹤0.01% | 540 |
|
2021
Q3 | $9K | Hold |
15
| – | – | ﹤0.01% | 530 |
|
2021
Q2 | $8K | Hold |
15
| – | – | ﹤0.01% | 509 |
|
2021
Q1 | $7K | Hold |
15
| – | – | ﹤0.01% | 501 |
|
2020
Q4 | $7K | Hold |
15
| – | – | ﹤0.01% | 472 |
|
2020
Q3 | $8K | Buy |
15
+5
| +50% | +$2.67K | ﹤0.01% | 440 |
|
2020
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 446 |
|
2020
Q1 | $5K | Hold |
10
| – | – | ﹤0.01% | 450 |
|
2019
Q4 | $4K | Sell |
10
-16
| -62% | -$6.4K | ﹤0.01% | 513 |
|
2019
Q3 | $7K | Buy |
26
+13
| +100% | +$3.5K | ﹤0.01% | 452 |
|
2019
Q2 | $4K | Hold |
13
| – | – | ﹤0.01% | 536 |
|
2019
Q1 | $5K | Buy |
13
+10
| +333% | +$3.85K | ﹤0.01% | 454 |
|
2018
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 509 |
|
2018
Q3 | – | Sell |
-3
| Closed | -$1K | – | 660 |
|
2018
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 518 |
|
2018
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 486 |
|
2017
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 469 |
|
2017
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 463 |
|
2017
Q2 | $1K | Hold |
3
| – | – | ﹤0.01% | 445 |
|
2017
Q1 | $1K | Sell |
3
-19
| -86% | -$6.33K | ﹤0.01% | 454 |
|
2016
Q4 | $8K | Sell |
22
-55
| -71% | -$20K | ﹤0.01% | 381 |
|
2016
Q3 | $31K | Buy |
+77
| New | +$31K | ﹤0.01% | 671 |
|
2014
Q4 | – | Sell |
-5
| Closed | -$2K | – | 583 |
|
2014
Q3 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 532 |
|